Table 1. Candidate antigens and selection criteria.
Gene | Locus tag | Fold change in vivo a | in vivo percentileb | Fold change in human urinec | Antigenicd | % UPEC (n = 55)e | % fecal (n = 30)e |
chuA | c4308 | 7.06 | 95.0 | 27.8 | + | 87 | 30 |
hma | c2482 | 6.56 | 94.5 | 14.8 | + | 69 | 17 |
iha | c3610 | 18.9 | 89.1 | 5.87 | + | 45 | 37 |
ireA | c5174 | 23.3 | 95.2 | 7.81 | + | 20 | 17 |
iroN | c1250 | 22.7 | 82.7 | 7.63 | + | 71 | 33 |
iutA | c3623 | 5.57 | 97.0 | 49.2 | + | 65 | 17 |
Transcript fold change in the urine of experimentally infected mice as compared to growth in LB [29].
Of 5379 genes ranked in order of in vivo transcript microarray signal intensity [29].
Protein fold change following growth in pooled filter-sterilized human urine as compared to growth in LB [30].
Reacts with sera from mice chronically infected with E. coli CFT073 [31].
Prevalence of indicated gene in UPEC and fecal isolates [31].